21 July, 2017
Relative strength index (RSI-14) for Aeterna Zentaris Inc. The current share price indicates that stock is -81.75% away from its one year high and is moving 30.50% ahead of its 52-week low. Its book value per share for the most recent quarter is $0.41 while its price to book ratio for the same period is 5.71, as for as the company's cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The company beat the analyst EPS Estimate with the difference of $0.11. AEterna Zentaris Inc. (USA) (NDAQ:AEZS) has declined 74.02% since July 20, 2016 and is downtrending. $3.50's average target is 49.57% above currents $2.34 stock price. Mr. Hickey will oversee the Company's business strategy planning function, developing and implementing a global strategic framework for AmTrust that reflects macro market trends and local market insights. In last 4 months performance of AFSI was -2.98% while its price to sale ratio is 0.45 and price to book ratio is 1.10. (AEZS)'s latest closing price distance was at -60.86% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 7.78% and 6.20% compared with the 20 Day Moving Average.
The Target Price for Aeterna Zentaris (NASDAQ:AEZS) is $2.5/share according to the consensus analysis of analysts working on the stock. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. Zacks Investment Research raised shares of AEterna Zentaris from a "sell" rating to a "hold" rating in a research note on Tuesday, July 11th. Consensus earnings estimates are far from ideal, but they are watched by many investors and play an important role in measuring the appropriate valuation for a stock.
AEterna Zentaris (NASDAQ:AEZS) (TSE:AEZ) last issued its quarterly earnings data on Monday, May 8th. Accern also assigned headlines about the biopharmaceutical company an impact score of 46.1118607446864 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term. The recommendation scale measures the value from 1 to 5, where 1 means "Buy" and 5 stands for "Sell". Equities research analysts forecast that AEterna Zentaris will post ($1.39) EPS for the current year.
Whereas they predicted High and Low Earnings Estimate as $-0.34 and $-0.41 respectively.
Aeterna Zentaris Inc. (NASDAQ:AEZS)'s stock has performed at -71.67%.
The company is expected to report earnings of $-0.39 a share for the next quarter. The Company Touched its 52-Week High on 10/20/16 and 52-Week Low on 05/09/17. More interesting news about AEterna Zentaris Inc. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
